Why Should PainReform Ltd (PRFX) Be In Your Portfolio?

EVTL

PainReform Ltd (NASDAQ:PRFX) has a beta value of 0.64 and has seen 18.41 million shares traded in the last trading session. The company, currently valued at $3.12M, closed the last trade at $3.57 per share which meant it gained $0.38 on the day or 11.91% during that session. The PRFX stock price is -1614.29% off its 52-week high price of $61.20 and 51.54% above the 52-week low of $1.73. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.96 million shares traded. The 3-month trading volume is 3.30 million shares.

PainReform Ltd (NASDAQ:PRFX) trade information

Sporting 11.91% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the PRFX stock price touched $3.57 or saw a rise of 46.32%. Year-to-date, PainReform Ltd shares have moved 6.41%, while the 5-day performance has seen it change 9.85%. Over the past 30 days, the shares of PainReform Ltd (NASDAQ:PRFX) have changed -32.64%. Short interest in the company has seen 55890.0 shares shorted with days to cover at 0.01.

PainReform Ltd (PRFX) estimates and forecasts

The company’s shares have lost -62.79% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -28.81% over the past 5 years.

PRFX Dividends

PainReform Ltd is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.